Recombinant Human TACI (TNFRSF13B)


TACI, a member of the TNF Receptor superfamily, is expressed in the small intestine, spleen, thymus, peripheral blood leukocytes, activated T cells, and resting B cells. TACI binds to both APRIL and BAFF and can stimulate the activation of transcription factors; NF-kappaB, AP-1, and mediates calcineurin dependent activation of NF-AT (nuclear-factor of activated T cells). TACI also plays a key role in the stimulation of B and T cell function. Soluble TACI inhibits APRIL-stimulated proliferation of primary B-cells by blocking the binding of APRIL to the membrane anchored TACI receptor. Recombinant human TACI is a soluble 159 amino acid polypeptide (17.8 kDa) comprising the TNFR homologous cysteine rich extracellular domain of the TACI protein. MK 2208 (dihydrochloride)


Source:
E. Coli
&nbsp

Purity:
Above 98% as determined by SDS-PAGE Analysis.
&nbsp

Cross Reactivity:
NULL
&nbsp

Biological Activity
Determined by its ability to block human BAFF induced T2B cell survival using a concentration range of 1.0-3.0 µg/ml.
&nbsp

AA Sequence
SGLGRSRRG GRSRVDQEE RFPQGLWTG VAMRSCPEE QYWDPLLGT CMSCKTICN HQSQRTCAA FCRSLSCRK EQGKFYDHL LRDCISCAS ICGQHPKQC AYFCENKLR SPVNLPPEL RRQRSGEVE NNSDNSGRY QGLEHRGSE ASPALPGLK LSADQV
Research Interest: , , Inflammation
Cell Type: ,
Protein Cross Reactivity: NULL

Availability: In stock

Size Price Qty
5µg

$80.00

20µg

$195.00

100µg

$850.00

500µg

$3,120.00

1mg

$5,200.00

MED: 19056988

Recombinant Human TACI (TNFRSF13B)


TACI, a member of the TNF Receptor superfamily, is expressed in the small intestine, spleen, thymus, peripheral blood leukocytes, activated T cells, and resting B cells. TACI binds to both APRIL and BAFF and can stimulate the activation of transcription factors; NF-kappaB, AP-1, and mediates calcineurin dependent activation of NF-AT (nuclear-factor of activated T cells). TACI also plays a key role in the stimulation of B and T cell function. Soluble TACI inhibits APRIL-stimulated proliferation of primary B-cells by blocking the binding of APRIL to the membrane anchored TACI receptor. Recombinant human TACI is a soluble 159 amino acid polypeptide (17.8 kDa) comprising the TNFR homologous cysteine rich extracellular domain of the TACI protein. PNU-159685


Source:
E. Coli
&nbsp

Purity:
Above 98% as determined by SDS-PAGE Analysis.
&nbsp

Cross Reactivity:
NULL
&nbsp

Biological Activity
Determined by its ability to block human BAFF induced T2B cell survival using a concentration range of 1.0-3.0 µg/ml.
&nbsp

AA Sequence
SGLGRSRRG GRSRVDQEE RFPQGLWTG VAMRSCPEE QYWDPLLGT CMSCKTICN HQSQRTCAA FCRSLSCRK EQGKFYDHL LRDCISCAS ICGQHPKQC AYFCENKLR SPVNLPPEL RRQRSGEVE NNSDNSGRY QGLEHRGSE ASPALPGLK LSADQV
Research Interest: , , Inflammation
Cell Type: ,
Protein Cross Reactivity: NULL

Availability: In stock

Size Price Qty
5µg

$80.00

20µg

$195.00

100µg

$850.00

500µg

$3,120.00

1mg

$5,200.00

MED: 19063842

Related Post